SCHEMBL874015

SCHEMBL874015

CCNc1nc(-c2ccc(NC(=O)c3cc4cccnc4s3)c(F)c2)ccc1C(=O)NCCN1CCCCC1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 1/20 0.41
DRD3 P35462 1/20 0.41
KCNH2 Q12809 4/20 0.40
CHRNA7 P36544 3/20 0.40
NAMPT P43490 1/20 0.39
PDPK1 O15530 1/20 0.38
IKBKB O14920 1/20 0.38
TMEM97 Q5BJF2 1/20 0.38
SIGMAR1 Q99720 1/20 0.38
MET P08581 2/20 0.38
IRAK4 Q9NWZ3 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
KDR P35968 1/20 0.37
KDM5B Q9UGL1 1/20 0.37
TGFBR1 P36897 1/20 0.36
TGFBR2 P37173 1/20 0.36
BTK Q06187 1/20 0.36
MAP4K4 O95819 1/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL874686 0.89 CYP3A4 (0.42) DRD2DRD3KCNH2CHRNA7NAMPT
SCHEMBL874016 0.85 NAMPT (0.37) DRD2DRD3KCNH2CHRNA7NAMPT
SCHEMBL873657 0.84 CYP3A4 (0.41) DRD2DRD3KCNH2CHRNA7NAMPT
SCHEMBL874151 0.81 CYP3A4 (0.40) DRD2DRD3KCNH2CHRNA7NAMPT
SCHEMBL486239 0.81 KCNH2 (0.43) KCNH2CHRNA7IKBKBKDRKDM5B
SCHEMBL874515 0.81 ATR (0.43) DRD2DRD3KCNH2CHRNA7NAMPT
SCHEMBL874058 0.81 NAMPT (0.42) DRD2DRD3KCNH2CHRNA7NAMPT
SCHEMBL486210 0.80 NAMPT (0.51) KCNH2CHRNA7NAMPTTGFBR1TGFBR2
SCHEMBL873820 0.80 ATR (0.46) DRD2DRD3KCNH2CHRNA7NAMPT
SCHEMBL485807 0.79 TGFBR1 (0.40) KCNH2CHRNA7NAMPTIKBKBKDM5B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012038905-A1 THIENOPYRIDINE NICOTINAMIDE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC USE THEREOF SANOFI (FR) 2012-03-29 WO disclosed